Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp (BIOX) delivers innovative agricultural technologies through integrated seed development, crop protection solutions, and biological nutrition products. This news hub provides stakeholders with essential updates about the company's advancements in sustainable farming solutions.
Access official press releases and curated news covering product launches, regulatory milestones, partnership announcements, and financial disclosures. Investors will find timely updates on BIOX's drought-tolerant seed technologies, biological crop inputs, and global market expansions.
Key content includes earnings reports, R&D breakthroughs in biotechnology, sustainability initiatives, and strategic collaborations. All materials are sourced from verified corporate communications to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to BIOX's latest developments in agricultural innovation. Regularly updated content supports informed analysis of the company's position in the agtech sector.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on February 9, 2023, at 8:30 a.m. ET, to discuss its second-quarter results ending December 31, 2022. The call, led by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Paula Savanti, will follow a press release with detailed financial data. Interested participants can access the call via toll-free and international dial-in numbers or through a live webcast, with a replay available until February 14, 2023.
Bioceres is focused on sustainable agriculture and offers innovative crop productivity solutions.
The merger between Calyxt and Cibus aims to create a leading entity in precision gene editing and sustainable agriculture. Under the all-stock deal, Calyxt shareholders will retain approximately 5% of the new company, which will operate under the name Cibus Inc. Key applications include enhancing productivity traits in seeds and developing renewable low-carbon ingredients. The merger supports a strong collaboration pipeline with major seed companies, with three productivity traits expected to launch in early 2023. Both companies anticipate significant regulatory developments that could enhance market opportunities.
On January 3, 2023, S&W Seed Company (SANW) and Trigall Genetics announced a joint venture, Trigall Australia, where Trigall Genetics will own 80%. This new entity aims to develop and market high-performing wheat varieties across Australia, utilizing S&W's commercial reach and Bioceres Crop Solutions' technologies. The program will include drought-resistant HB4 technology and EcoWheat technologies to enhance yields in drought-affected areas. The partnership marks a significant step in Trigall's international expansion strategy, leveraging a global genetic library and advanced breeding expertise.
Bioceres Crop Solutions Corp. (BIOX) reported a 71% increase in revenues for 1Q23, totaling $127.1 million, compared to pro forma figures from 1Q22. Gross profit rose 52% to $51.4 million, while Adjusted EBITDA nearly doubled, reaching $24.5 million. The growth was driven by strong sales of micro-beaded fertilizers and biological products. A significant agreement with Syngenta Seedcare aims to enhance global inoculant growth, with a minimum profit share of $23 million per year. Despite a severe drought in Argentina, management remains optimistic about future growth.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on November 10, 2022, at 8:30 a.m. ET to discuss its first quarter results for the period ending September 30, 2022. CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Paula Savanti will lead the discussion, followed by a Q&A session. Investors can join via a toll-free number and access the call through a webcast. A replay will be available until November 15, 2022.
Syngenta Seedcare has partnered with Bioceres Crop Solutions (NASDAQ: BIOX) to exclusively commercialize its biological seed treatment solutions globally. This collaboration, stemming from a productive 20-year relationship, aims to accelerate the registration of existing products while jointly developing new solutions. The biological seed treatment market is expected to grow from $0.6 billion in 2020 to $1.6 billion by 2030. The agreement will enhance the availability of sustainable farming solutions while focusing on key markets like Brazil and China.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported strong financial results for the fourth quarter and fiscal year ended June 30, 2022. The fourth quarter saw a 44% increase in comparable revenues to $104.1 million, while full fiscal year revenues rose 62% to a record $319.3 million. HB4 Wheat revenues of $12.4 million marked a 94% increase YoY. Gross profit for the quarter was $41.4 million, a 32% increase, and Adjusted EBITDA reached $61.9 million, up 24%.
Successful mergers and ongoing regulatory approvals for HB4 products further bolster the company’s growth prospects.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced a conference call on September 8, 2022, at 8:30 a.m. ET to discuss its fourth quarter and fiscal year results for the period ending June 30, 2022. The call will feature key executives, including CEO Federico Trucco and CFO Enrique Lopez Lecube, and will include a Q&A session. A press release with detailed results will precede the call, and a replay will be available until September 13, 2022.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) has finalized capital commitments related to its merger with Marrone Bio Innovations, issuing secured guaranteed convertible notes worth $55 million with a 4-year maturity at an interest rate of 9%. The proceeds will address financial obligations of ProFarm Group and support merger synergies. Additionally, Bioceres issued new secured notes for $24.4 million to cover remaining convertible notes from 2020. Both note issuances aim to enhance operational efficiency while maintaining a strong financial structure.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will participate in the Canaccord Genuity 42nd Annual Growth Conference from August 8-11, 2022, in Boston, MA. Key executives, including Chairman Federico Trucco and CFO Enrique Lopez Lecube, will conduct one-on-one meetings to discuss the company’s recent acquisition of Marrone Bio Innovations and HB4® Wheat and Soy approvals on August 10-11. Bioceres will also present on August 11 from 11:00-11:25 AM ET. For more details, visit the conference website or contact investor relations.
